With about 70 patents, series of fundings, and an innovative product line, primarily to address the prevention and removal of microbial biofilms, finally the 19-year-old company makes it big in the bioscience industry!
CanAscen’s business concept is to be a differentiated leader in the premium segment of the cannabinoid market. The CanAscen Group (CAG) will achieve this through technological partnerships with established and successful producers of a variety of cannabinoid products.
The CanAscen Group is a collective of experts and specialists striving to create premium products for global connoisseurs
The CanAscen Group is uniquely positioned with expertise in multiple vertical sectors; Cannabis, Science, Agriculture and Business internationally. With the synergism of the team, and a view to the future our team is well-positioned to ensure CAG’s leadership in the global cannabis space.